Inspire Medical Systems (NYSE:INSP) Raised to “Strong-Buy” at Freedom Capital

Inspire Medical Systems (NYSE:INSP) was upgraded by investment analysts at Freedom Capital to a “strong-buy” rating in a research note issued to investors on Tuesday,Zacks.com reports.

Several other research firms also recently weighed in on INSP. Zacks Research lowered shares of Inspire Medical Systems from a “hold” rating to a “strong sell” rating in a research report on Wednesday, May 13th. Stifel Nicolaus dropped their price target on Inspire Medical Systems from $70.00 to $65.00 and set a “buy” rating on the stock in a research note on Tuesday, May 5th. Weiss Ratings lowered Inspire Medical Systems from a “sell (d+)” rating to a “sell (d)” rating in a report on Wednesday, May 6th. Evercore cut shares of Inspire Medical Systems from an “outperform” rating to an “in-line” rating and set a $40.00 price target for the company. in a report on Tuesday, June 23rd. Finally, Royal Bank Of Canada downgraded Inspire Medical Systems from a “sector perform” rating to a “buy” rating in a research note on Monday, June 15th. One investment analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, thirteen have issued a Hold rating and three have given a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $81.05.

Inspire Medical Systems Stock Up 3.3%

Shares of NYSE INSP opened at $46.95 on Tuesday. The stock has a market capitalization of $1.35 billion, a P/E ratio of 10.46, a P/E/G ratio of 4.60 and a beta of 0.71. Inspire Medical Systems has a 52-week low of $38.91 and a 52-week high of $147.03. The firm’s 50-day moving average price is $44.71 and its two-hundred day moving average price is $62.53.

Inspire Medical Systems (NYSE:INSP) last released its quarterly earnings data on Monday, May 4th. The company reported $0.10 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.28) by $0.38. Inspire Medical Systems had a return on equity of 10.35% and a net margin of 14.33%.The business had revenue of $204.58 million during the quarter, compared to analyst estimates of $200.04 million. During the same quarter in the previous year, the firm posted $0.10 EPS. The business’s revenue for the quarter was up 1.6% compared to the same quarter last year. Inspire Medical Systems has set its FY 2026 guidance at 0.750-1.250 EPS. As a group, equities research analysts expect that Inspire Medical Systems will post 0.93 earnings per share for the current year.

Hedge Funds Weigh In On Inspire Medical Systems

Several large investors have recently bought and sold shares of INSP. Xponance Inc. increased its stake in shares of Inspire Medical Systems by 2.9% during the third quarter. Xponance Inc. now owns 4,177 shares of the company’s stock worth $310,000 after purchasing an additional 116 shares during the period. Daiwa Securities Group Inc. raised its position in shares of Inspire Medical Systems by 38.7% in the 2nd quarter. Daiwa Securities Group Inc. now owns 466 shares of the company’s stock valued at $60,000 after buying an additional 130 shares in the last quarter. State of Wyoming raised its position in Inspire Medical Systems by 31.5% during the fourth quarter. State of Wyoming now owns 731 shares of the company’s stock valued at $67,000 after purchasing an additional 175 shares in the last quarter. Smartleaf Asset Management LLC boosted its stake in Inspire Medical Systems by 84.0% in the fourth quarter. Smartleaf Asset Management LLC now owns 449 shares of the company’s stock valued at $42,000 after buying an additional 205 shares in the last quarter. Finally, Apollon Wealth Management LLC boosted its stake in shares of Inspire Medical Systems by 5.6% in the 1st quarter. Apollon Wealth Management LLC now owns 3,997 shares of the company’s stock valued at $206,000 after purchasing an additional 212 shares in the last quarter. 94.91% of the stock is currently owned by institutional investors and hedge funds.

Inspire Medical Systems Company Profile

Inspire Medical Systems, Inc is a medical technology company specializing in implantable neurostimulation devices for the treatment of obstructive sleep apnea (OSA). The company’s flagship offering, the Inspire® system, delivers targeted stimulation of the hypoglossal nerve to maintain airway patency during sleep, providing an alternative therapy for patients who are intolerant of or inadequately managed by continuous positive airway pressure (CPAP) devices.

The Inspire system comprises an implantable pulse generator, a sensing lead that monitors breathing patterns, and a stimulation lead that activates the hypoglossal nerve.